Literature DB >> 16858208

On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer.

Michael C Garofalo, William F Regine, Ming T Tan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16858208      PMCID： PMC1602155          DOI： 10.1097/01.sla.0000229980.81505.44

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  Chemotherapy for pancreatic cancer.

Authors:  Stephen L Morris; Matthew Beasley; Martin Leslie
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

2.  Chemotherapy for pancreatic cancer.

Authors:  Christopher H Crane; Edgar Ben-Josef; William Small
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

3.  Adjuvant therapy for pancreatic cancer--the debate continues.

Authors:  Michael A Choti
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

4.  Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

Authors:  J H Klinkenbijl; J Jeekel; T Sahmoud; R van Pel; M L Couvreur; C H Veenhof; J P Arnaud; D G Gonzalez; L T de Wit; A Hennipman; J Wils
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

5.  Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group.

Authors: 
Journal:  Cancer       Date:  1987-06-15       Impact factor: 6.860

6.  Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.

Authors:  M H Kalser; S S Ellenberg
Journal:  Arch Surg       Date:  1985-08

7.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Authors:  John P Neoptolemos; Deborah D Stocken; Helmut Friess; Claudio Bassi; Janet A Dunn; Helen Hickey; Hans Beger; Laureano Fernandez-Cruz; Christos Dervenis; François Lacaine; Massimo Falconi; Paolo Pederzoli; Akos Pap; David Spooner; David J Kerr; Markus W Büchler
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245
  7 in total
  26 in total

1.  Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer.

Authors:  Charles C Hsu; Christopher L Wolfgang; Daniel A Laheru; Timothy M Pawlik; Michael J Swartz; Jordan M Winter; Raymond Robinson; Barish H Edil; Amol K Narang; Michael A Choti; Ralph H Hruban; John L Cameron; Richard D Schulick; Joseph M Herman
Journal:  J Gastrointest Surg       Date:  2012-02-07       Impact factor: 3.452

Review 2.  Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal".

Authors:  Paula Ghaneh; Catrin Tudur-Smith; John P Neoptolemos
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Controversies in the adjuvant treatment of pancreas cancer: a lack of knowledge or simply a lack of will?

Authors:  Emily Chan; Jordan D Berlin
Journal:  Gastrointest Cancer Res       Date:  2007-09

4.  The role of radiotherapy in management of pancreatic cancer.

Authors:  Fen Wang; Parvesh Kumar
Journal:  J Gastrointest Oncol       Date:  2011-09

5.  Outcomes of resected pancreatic cancer in patients age ≥70.

Authors:  Thomas J Hayman; Tobin Strom; Gregory M Springett; Lodovico Balducci; Sarah E Hoffe; Kenneth L Meredith; Pamela Hodul; Mokenge Malafa; Ravi Shridhar
Journal:  J Gastrointest Oncol       Date:  2015-10

Review 6.  Adjuvant therapy in pancreatic cancer: a critical appraisal.

Authors:  Helmut Oettle; Peter Neuhaus
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 7.  Postoperative radiotherapy in periampullary cancers: a brief review.

Authors:  Amit Bahl; Tapesh Bhattacharyya; Rakesh Kapoor; Oinam A Singh; Tomar Parsee; Suresh C Sharma
Journal:  J Gastrointest Cancer       Date:  2013-03

Review 8.  Approaches to localized pancreatic cancer.

Authors:  Martin Loos; Jörg Kleeff; Helmut Friess; Markus W Büchler
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

9.  Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data.

Authors:  Krisha J Opfermann; Amy E Wahlquist; Elizabeth Garrett-Mayer; Ravi Shridhar; Leander Cannick; David T Marshall
Journal:  Am J Clin Oncol       Date:  2014-04       Impact factor: 2.339

10.  Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.

Authors:  Charles C Hsu; Joseph M Herman; Michele M Corsini; Jordan M Winter; Matthew D Callister; Michael G Haddock; John L Cameron; Timothy M Pawlik; Richard D Schulick; Christopher L Wolfgang; Daniel A Laheru; Michael B Farnell; Michael J Swartz; Leonard L Gunderson; Robert C Miller
Journal:  Ann Surg Oncol       Date:  2010-01-20       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.